SK18962000A3 - Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK18962000A3
SK18962000A3 SK1896-2000A SK18962000A SK18962000A3 SK 18962000 A3 SK18962000 A3 SK 18962000A3 SK 18962000 A SK18962000 A SK 18962000A SK 18962000 A3 SK18962000 A3 SK 18962000A3
Authority
SK
Slovakia
Prior art keywords
tetrahydro
naphthyridin
trimethyl
alkyl
disorders
Prior art date
Application number
SK1896-2000A
Other languages
English (en)
Slovak (sk)
Inventor
John David Harling
Frank Peter Harrington
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK18962000A3 publication Critical patent/SK18962000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1896-2000A 1998-06-12 1999-06-09 Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie SK18962000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812683.2A GB9812683D0 (en) 1998-06-12 1998-06-12 Novel compounds
PCT/GB1999/001826 WO1999065903A1 (en) 1998-06-12 1999-06-09 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity

Publications (1)

Publication Number Publication Date
SK18962000A3 true SK18962000A3 (sk) 2001-08-06

Family

ID=10833636

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1896-2000A SK18962000A3 (sk) 1998-06-12 1999-06-09 Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (31)

Country Link
US (2) US6410555B1 (de)
EP (1) EP1084122B1 (de)
JP (1) JP2002518390A (de)
KR (1) KR20010052792A (de)
CN (1) CN1311789A (de)
AP (1) AP2000002009A0 (de)
AR (1) AR018656A1 (de)
AT (1) ATE252579T1 (de)
AU (1) AU750470B2 (de)
BG (1) BG105126A (de)
BR (1) BR9911110A (de)
CA (1) CA2334900A1 (de)
CO (1) CO5040081A1 (de)
CZ (1) CZ293010B6 (de)
DE (1) DE69912278T2 (de)
EA (1) EA200100033A1 (de)
ES (1) ES2209524T3 (de)
GB (1) GB9812683D0 (de)
HU (1) HUP0102773A3 (de)
ID (1) ID27593A (de)
IL (1) IL140171A0 (de)
MA (1) MA26646A1 (de)
NO (1) NO20006269L (de)
NZ (1) NZ508799A (de)
PE (1) PE20000727A1 (de)
PL (1) PL344791A1 (de)
SK (1) SK18962000A3 (de)
TR (1) TR200003694T2 (de)
TW (1) TW495510B (de)
WO (1) WO1999065903A1 (de)
ZA (1) ZA200007397B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
EP1243263B1 (de) * 2001-03-21 2002-11-27 Schwarz Pharma Ag Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
CA2624625A1 (en) * 2005-11-04 2007-05-10 Pfizer Limited Tetrahydronaphthyridine derivative
JP6378182B2 (ja) * 2012-08-27 2018-08-22 アレイ バイオファーマ、インコーポレイテッド 過剰増殖性│疾患の処置のためのセリン/スレオニンキナーゼ阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
CZ416498A3 (cs) 1996-06-17 1999-06-16 Smithkline Beecham Plc Substituovaný benzamidový derivát a jeho použití jako antikonvulsantu
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
DE69912278T2 (de) 2004-08-12
DE69912278D1 (en) 2003-11-27
ATE252579T1 (de) 2003-11-15
AP2000002009A0 (en) 2000-12-31
WO1999065903A1 (en) 1999-12-23
CA2334900A1 (en) 1999-12-23
US6762192B2 (en) 2004-07-13
TW495510B (en) 2002-07-21
ID27593A (id) 2001-04-12
NZ508799A (en) 2003-08-29
PE20000727A1 (es) 2000-09-28
EP1084122A1 (de) 2001-03-21
US20020143029A1 (en) 2002-10-03
NO20006269D0 (no) 2000-12-11
AR018656A1 (es) 2001-11-28
EP1084122B1 (de) 2003-10-22
BR9911110A (pt) 2001-10-30
KR20010052792A (ko) 2001-06-25
MA26646A1 (fr) 2004-12-20
AU4280099A (en) 2000-01-05
CZ20004611A3 (en) 2001-06-13
ZA200007397B (en) 2002-02-27
JP2002518390A (ja) 2002-06-25
IL140171A0 (en) 2002-02-10
AU750470B2 (en) 2002-07-18
CN1311789A (zh) 2001-09-05
HUP0102773A3 (en) 2002-09-30
CZ293010B6 (cs) 2004-01-14
NO20006269L (no) 2001-02-07
PL344791A1 (en) 2001-11-19
TR200003694T2 (tr) 2001-06-21
HUP0102773A2 (hu) 2002-01-28
GB9812683D0 (en) 1998-08-12
ES2209524T3 (es) 2004-06-16
EA200100033A1 (ru) 2001-06-25
BG105126A (en) 2001-11-30
CO5040081A1 (es) 2001-05-29
US6410555B1 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
JP2944048B2 (ja) 二環式テトラヒドロピラゾロピリジン
KR100235277B1 (ko) 피라졸로- 및 피롤로-피리딘
US6818646B2 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
EP0858996B1 (de) Mittel zum schutz von nervenzellen
US8952158B2 (en) Tricyclic compound and use thereof
KR101216296B1 (ko) 티에노피리디논 화합물 및 치료 방법
JP2019513745A (ja) ピロロ[1,2−a]ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用
AU2010200563A1 (en) Bicyclic amides for enhancing glutamatergic synaptic responses
PL192116B1 (pl) Pochodne izochinoliny, zawierająca je kompozycja farmaceutyczna oraz zastosowanie pochodnych izochinoliny
CZ416498A3 (cs) Substituovaný benzamidový derivát a jeho použití jako antikonvulsantu
SK9142000A3 (en) Tetrahydro isoquinolinyl carboxamide compounds, preparation thereof, pharmaceutical composition containing them and their use
JP2001518908A (ja) ピリダジンおよびフタラジン誘導体、それらの製造方法および抗痙攣剤としてのそれらの使用
US20230355593A1 (en) N-methyl-D-aspartic Acid Receptor Modulators
SK18962000A3 (sk) Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
SK126799A3 (en) Isoquinolyl-benzamide derivatives, process for their production, pharmaceutical composition containing them and their use
JP2001517668A (ja) N−5,6,7,8−テトラヒドロ(1、6)ナフチリジン−n’−フェニルウレア誘導体
JP2002522436A (ja) 三環式カルボキシアミド類
JP2002501517A (ja) 1,6−ナフチリジン抗痙攣薬
CZ20014721A3 (cs) Nové sloučeniny
JP2001519798A (ja) 抗痙攣作用を有するピリミド−イソキノリン化合物
MXPA00012322A (en) Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
CZ20002221A3 (cs) Substituované deriváty isochinolinu a jejich použití jako antikonvulziva
JPWO2001079206A1 (ja) 三環性キナゾリンジオン類